Voclosporin
AUR-VCS-2017-03
Phase 2 small_molecule terminated
Quick answer
Voclosporin for Focal Segmental Glomerulosclerosis is a Phase 2 program (small_molecule) at Aurinia Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aurinia Pharmaceuticals
- Indication
- Focal Segmental Glomerulosclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated